Cetera Trust Company’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Buy
6,910
+120
+2% +$5.36K 0.15% 130
2026
Q1
$327K Hold
6,790
0.18% 106
2025
Q4
$329K Buy
6,790
+650
+11% +$32.2K 0.18% 105
2025
Q3
$290K Hold
6,140
0.16% 122
2025
Q2
$297K Buy
6,140
+250
+4% +$12.8K 0.18% 108
2025
Q1
$327K Hold
5,890
0.21% 84
2024
Q4
$284K Buy
5,890
+150
+3% +$7.63K 0.18% 100
2024
Q3
$331K Hold
5,740
0.2% 94
2024
Q2
$279K Hold
5,740
0.17% 103
2024
Q1
$279K Sell
5,740
-300
-5% -$14.6K 0.17% 111
2023
Q4
$300K Buy
+6,040
New +$295K 0.19% 95

Other funds holding SNY

Cetera Trust Company's SNY Position: Q2 2026 in Review

Cetera Trust Company increased its Sanofi (SNY) stake by 1.8% in Q2 2026, buying an estimated $5.36K and bringing the position to 6,910 shares worth $295K. The position accounts for 0.15% of the portfolio, ranked #130.

Cetera Trust Company first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $331K in Q3 2024. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Cetera Trust Company held 6,910 shares of Sanofi worth $295K as of Q2 2026.
  • Cetera Trust Company bought 120 Sanofi shares in Q2 2026, an estimated $5.36K.
  • Sanofi made up 0.15% of Cetera Trust Company's portfolio in Q2 2026, its #130 holding.
  • Cetera Trust Company first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
  • Cetera Trust Company's Sanofi position peaked at $331K in Q3 2024.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.